Medifast Inc reports results for the quarter ended June 30 - Earnings Summary

• Medifast Inc MED reported quarterly adjusted earnings of 22 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 92 cents. The lone analyst forecast for the quarter was for a loss of 22 cents per share.

• Revenue fell 37.4% to $105.56 million from a year ago; analysts expected $96.10 million.

• Medifast Inc's reported EPS for the quarter was 22 cents​.

• The company reported quarterly net income of $2.48 million.

• Medifast Inc shares had fallen by 2.1% this quarter and lost 22.0% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the food processing peer group is "buy."

• Wall Street's median 12-month price target for Medifast Inc is $15.00, about 9.9% above its last closing price of $13.51

This summary was machine generated from LSEG data August 4 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)